eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | c syndrome |
| Comorbidity | |type 2 diabetes |
| Sentences | 72 |
| PubMedID- 24601861 | This study aims to assess the prevalence of the components of the metabolic syndrome in type 2 diabetes mellitus (t2dm) patients using the international diabetes federation (idf) worldwide definition. |
| PubMedID- 25867398 | Associations between genetic variants and the severity of metabolic syndrome in subjects with type 2 diabetes. |
| PubMedID- 24462884 | Background: alstrom syndrome is a recessively inherited condition characterised by severe insulin resistance and metabolic syndrome with progression to type 2 diabetes, hepatic dysfunction and coronary artery disease. |
| PubMedID- 20695946 | Raised plasma urotensin ii in type 2 diabetes patients is associated with the metabolic syndrome phenotype. |
| PubMedID- 26097823 | Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. |
| PubMedID- 23728331 | type 2 diabetes mellitus with metabolic syndrome developed at 30 weeks of age, and the body weights and plasma insulin levels of oletf rats at 60 weeks of age were lower than those of normal rats. |
| PubMedID- 25760026 | Insulin resistance is a common pathological state found in the metabolic syndromeassociated with obesity and type 2 diabetes mellitus, in which target tissues fail torespond properly to physiologic insulin levels (5,7). |
| PubMedID- 23115071 | Introduction: at present, little data exists about the incidence of, and the risk factors associated with, metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22809366 | In addition, fatty liver is a manifestation of metabolic syndrome, and is associated with obesity, type 2 diabetes mellitus (t2dm), and hypertriglyceridemia [11]. |
| PubMedID- 20178560 | Patients with chc may develop hepatic steatosis as a consequence of concomitant metabolic syndrome, possibly associated with type 2 diabetes, obesity or increased body mass index (bmi). |
| PubMedID- 22669833 | Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus. |
| PubMedID- 20305326 | The association between ace i/d polymorphism and metabolic syndrome in type 2 diabetes, was not significant (p=0.204). |
| PubMedID- 20586225 | The consequence is a metabolic syndrome with type 2 diabetes and increased cardiovascular mortality. |
| PubMedID- 22755342 | Metabolic syndrome in type 2 diabetes: comparison of who, modified atpiii & idf criteria. |
| PubMedID- 21936688 | Metabolic syndrome (mets) is associated with development of type 2 diabetes mellitus and increased risk for cardiovascular disease. |
| PubMedID- 22204179 | Conclusion: this study showed a high prevalence of the metabolic syndrome in subjects with type 2 diabetes. |
| PubMedID- 20927114 | Therefore, we focused on the spontaneously hypertensive corpulent rat (shr/n-cp), a model with type 2 diabetes, obesity and features of the metabolic syndrome to characterize retinal changes at a structural and functional level. |
| PubMedID- 24816278 | Hepatic manifestations of the metabolic syndrome (hmms) are associated with obesity, type 2 diabetes/insulin resistance, non-alcoholic fatty liver disease (nafld), and progression to non-alcoholic steatohepatitis (nash) [1]. |
| PubMedID- 20028945 | Changes in adipose tissue distribution could accompany significant improvements in the components of the metabolic syndrome in individuals with type 2 diabetes (35–36); however, we did not find that the relationships specifically between improvements in the adipose tissue distribution and improvements in the peripheral insulin sensitivity were independent of the change in overall weight and adipose tissue mass. |
| PubMedID- 25561880 | Aim: the dietary contents have a very important role in the management of metabolic syndrome along with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25737976 | Aims and objectives: to study the prevalence of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 24171882 | Prevalence of metabolic syndrome in type 2 diabetes mellitus using ncep-atpiii, idf and who definition and its agreement in gwalior chambal region of central india. |
Page: 1 2